Literature DB >> 11204447

Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/- mouse model within six months.

L Liu1, H Hu, H Ji, A D Murdin, G N Pierce, G Zhong.   

Abstract

We have previously shown that infection with the C. pneumoniae AR39 strain once monthly for 9 consecutive months significantly exacerbated atherosclerosis in mice with LDL receptor deficiency (LDLR-/-) in the presence of a high cholesterol diet. To further optimize the LDLR-/- mouse model for studying the mechanisms of C. pneumoniae atherogenesis, we have tested a different infection protocol with intranasal inoculation twice monthly for 6 consecutive months in the present study. We found that C. pneumoniae infection for 6 months was sufficient to produce a 130%, significantly greater exacerbation of aortic atherosclerosis in LDLR-/- mice in the presence of a high cholesterol diet. Mice receiving a high cholesterol diet alone displayed a lesion area index of 18.2 +/- 6.1 (S.D.) while mice treated with both the high cholesterol diet and C. pneumoniae infection had a lesion area index of 41.8 +/- 15.2 (S.D.). However, the chlamydial infection did not significantly alter the mouse serum total cholesterol or the LDL levels induced by the high cholesterol diet. This study not only confirms our previous findings that C. pneumoniae infection can exacerbate aortic atherosclerosis lesion in the LDLR-/- mice, but also further optimizes the LDLR-/- mouse model for future mechanism studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11204447     DOI: 10.1023/a:1026531506202

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  41 in total

Review 1.  Chlamydia pneumoniae and atherosclerosis--an update.

Authors:  P Saikku
Journal:  Scand J Infect Dis Suppl       Date:  1997

2.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

3.  Chlamydia pneumoniae and atherosclerosis: links to the disease process.

Authors:  G I Byrne; M V Kalayoglu
Journal:  Am Heart J       Date:  1999-11       Impact factor: 4.749

4.  In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells.

Authors:  T C Quinn; C A Gaydos
Journal:  Am Heart J       Date:  1999-11       Impact factor: 4.749

5.  Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group.

Authors:  J A Ramirez
Journal:  Ann Intern Med       Date:  1996-12-15       Impact factor: 25.391

6.  Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.

Authors:  T C Moazed; L A Campbell; M E Rosenfeld; J T Grayston; C C Kuo
Journal:  J Infect Dis       Date:  1999-07       Impact factor: 5.226

7.  Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae.

Authors:  M V Kalayoglu; B Hoerneman; D LaVerda; S G Morrison; R P Morrison; G I Byrne
Journal:  J Infect Dis       Date:  1999-09       Impact factor: 5.226

8.  IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.

Authors:  S Gupta; A M Pablo; X c Jiang; N Wang; A R Tall; C Schindler
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

Review 9.  Chlamydia pneumoniae and cardiovascular disease.

Authors:  L A Campbell; C C Kuo; J T Grayston
Journal:  Emerg Infect Dis       Date:  1998 Oct-Dec       Impact factor: 6.883

10.  Immunogenicity evaluation of a lipidic amino acid-based synthetic peptide vaccine for Chlamydia trachomatis.

Authors:  G Zhong; I Toth; R Reid; R C Brunham
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

View more
  15 in total

1.  Chlamydia pneumoniae secretion of a protease-like activity factor for degrading host cell transcription factors required for [correction of factors is required for] major histocompatibility complex antigen expression.

Authors:  Peiyi Fan; Feng Dong; Yanqing Huang; Guangming Zhong
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

2.  Heat-inactivated C. pneumoniae organisms are not atherogenic.

Authors:  Jyotika Sharma; Yuhong Niu; Jianbo Ge; Grant N Pierce; Guangming Zhong
Journal:  Mol Cell Biochem       Date:  2004-05       Impact factor: 3.396

3.  Localization of the hypothetical protein Cpn0797 in the cytoplasm of Chlamydia pneumoniae-infected host cells.

Authors:  Feng Dong; Rhonda Flores; Ding Chen; Jianhua Luo; Youmin Zhong; Zhongming Wu; Guangming Zhong
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

4.  Hypothetical protein Cpn0308 is localized in the Chlamydia pneumoniae inclusion membrane.

Authors:  Jianhua Luo; Tianjun Jia; Rhonda Flores; Ding Chen; Guangming Zhong
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

5.  Molecular detection and seroepidemiology of the Chlamydia pneumoniae bacteriophage (PhiCpn1).

Authors:  Karuna P Karunakaran; James F Blanchard; Ausra Raudonikiene; Caixia Shen; Andrew D Murdin; Robert C Brunham
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

6.  Chlamydia pneumoniae--induced macrophage foam cell formation is mediated by Toll-like receptor 2.

Authors:  Fei Cao; Antonio Castrillo; Peter Tontonoz; Fabio Re; Gerald I Byrne
Journal:  Infect Immun       Date:  2006-12-04       Impact factor: 3.441

7.  Production of a proteolytically active protein, chlamydial protease/proteasome-like activity factor, by five different Chlamydia species.

Authors:  Feng Dong; Youmin Zhong; Bernard Arulanandam; Guangming Zhong
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

8.  Amalgamation of Chlamydia pneumoniae inclusions with lipid droplets in foam cells in human atherosclerotic plaque.

Authors:  Yuri V Bobryshev; Murray C Killingsworth; Dihn Tran; Reginald Lord
Journal:  Virchows Arch       Date:  2008-06-06       Impact factor: 4.064

Review 9.  The role of the vascular dendritic cell network in atherosclerosis.

Authors:  Noah Alberts-Grill; Timothy L Denning; Amir Rezvan; Hanjoong Jo
Journal:  Am J Physiol Cell Physiol       Date:  2013-04-03       Impact factor: 4.249

10.  Chlamydia pneumoniae Infection and Inflammatory Diseases.

Authors:  Rebecca A Porritt; Timothy R Crother
Journal:  For Immunopathol Dis Therap       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.